Improved Access to Quality Care and Healthcare Use

The Impact of Access to Higher-quality Care Services on Health-seeking Patterns

This study is an individual-level randomised controlled trial which looks at the effect of providing free access to higher quality providers in urban South Africa. The study will recruit about 1,500 individuals with a child aged 5 or under. They will be randomly allocate to a control group (CONTROL) with the default free access to government facilities or one of the two treatment groups where they will have free access to private providers located either relatively close (CONVENIENT) by or relatively far (INCONVENIENT). The primary outcomes be overuse and underuse of healthcare services for children under 5

Study Overview

Detailed Description

In many low-income settings, provision of social services by the public sector is plagued by problems of quality and low accountability to users. As a result, low expected benefits or fear of neglect by service providers may delay the use of needed services, even when those are free.

In South Africa, the health system is characterised by stark inequalities, with most of the population only able to seek care in free government facilities. The low quality of the public sector, where patients wait long times to be seen by nurses, is believed to lead many to delay needed care and prevent health outcome improvement. The government of South Africa is developing proposals to introduce a national health insurance scheme that would provide free access to private providers who deliver higher care quality. However, concerns about the unequal geographical distribution of private providers raise questions about the potential benefits of the reform. This study asks several questions to inform this reform:

  1. Does access to higher-quality care reduce under-use of services for children but also increase overuse?
  2. Does access to higher-quality care lead to improved health knowledge of parents and better health outcomes for children?
  3. Are these effects mitigated by the distance to the contracted providers? A randomised controlled trial is used to answer these questions. The study will recruit about 1,500 individuals who are the primary caregiver of at least one child aged six or under. and randomly allocate them to a control group (CONTROL) with the default free access to government facilities or one of the two treatment groups where they will have free access to private providers located either relatively close (CONVENIENT) by or relatively far (INCONVENIENT).

The primary outcomes will be the proportion of visits that are considered unnecessary (overuse) and the number of days of illness where care-seeking is recommended by guidelines but not sought by the child's parent or guardian.

Secondary outcomes will include (1) the number of days with ill-health symptoms; (2) out-of-pocket expenditures; (3) health knowledge of parents; (4) subjective and (5) objective measures of child's health.

Study Type

Interventional

Enrollment (Estimated)

1500

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • parent has a child aged under 6 years old and over 2 months old

Exclusion Criteria:

  • is planning to move out of the area in the next 3 months
  • has private medical aid

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control group
In this group, participants will have free access to government facilities (usual care)
Experimental: Convenient group
In this group, for the duration of the study, participants will be given free access to a small number of private providers located relatively close by (less than 30 minutes).
Participants are able to take their child to receive free consultations and treatment in a network of contracted private healthcare providers.
The network of contracted providers is located close to where participants live.
Experimental: Inconvenient group
In this group, for the duration of the study, participants will be given free access to a small number of private providers located relatively far (about one hour).
Participants are able to take their child to receive free consultations and treatment in a network of contracted private healthcare providers.
The network of contracted providers is located far to where participants live.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Underuse
Time Frame: 12 weeks
number of days of illness where care-seeking is recommended by guidelines but not sought by the child's parent or guardian
12 weeks
Overuse
Time Frame: 12 weeks
proportion of primary health care visits that are considered unnecessary
12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Illness duration
Time Frame: 12 weeks
number of days with ill-health symptoms
12 weeks
Out-of-pocket expenditures
Time Frame: 12 weeks
Direct (consultations, drugs) and indirect (transport) expenditures spent on health care
12 weeks
Health knowledge
Time Frame: Endline survey (i.e. 12 weeks approximately after the start of the intervention)
Index of knowledge of parents in relation to preventive and curative care. Parents will answer as series of knowledge questions relative to care-seeking patterns for children (with correct and incorrect responses). For each individual, a score will be computing by adding up all of the correct responses (1 point per correct response, 0 for incorrect), so a higher score will reflect a better knowledge.
Endline survey (i.e. 12 weeks approximately after the start of the intervention)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Mylene Lagarde, PhD, London School of Economics and Political Science

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 20, 2024

Primary Completion (Estimated)

June 10, 2024

Study Completion (Estimated)

August 30, 2024

Study Registration Dates

First Submitted

February 8, 2024

First Submitted That Met QC Criteria

February 16, 2024

First Posted (Actual)

February 23, 2024

Study Record Updates

Last Update Posted (Actual)

February 23, 2024

Last Update Submitted That Met QC Criteria

February 16, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • SOPRIMA//T023635

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Health, Subjective

Clinical Trials on Free high-quality care

3
Subscribe